查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2008300

草銨膦市場：2026-2032年全球市場預測（依作物、製劑、應用及最終用途分類）

Glufosinate Market by Crop, Formulation, Application, End Use - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，草銨膦市場價值將達到 21.7 億美元，到 2026 年將成長至 23.9 億美元，到 2032 年將達到 42.9 億美元，複合年成長率為 10.21%。

主要市場統計數據
基準年 2025 21.7億美元
預計年份：2026年 23.9億美元
預測年份 2032 42.9億美元
複合年成長率 (%) 10.21%

草銨膦發展趨勢概述：農業應用、監管壓力、供應鏈趨勢及商業性意義

草銨膦在現代農業科學中佔據獨特的地位，它既是綜合雜草控制方案中Glyphosate的替代品，也是抗性管理策略的補充。其除草機制、監管特性和製劑柔軟性使其在各種種植系統中保持著重要性，但由於監管力度的加強和生產者偏好的改變，其使用也在不斷發展。近幾個種植季，相關人員推動了製劑、施用時間和正確使用方法的創新，力求在藥效、環境和監管因素之間取得平衡。

監管、農業、技術和商業變革因素正在重塑草銨膦的策略創新及其在供應鏈中的地位。

在監管審查、抗藥性管理需求以及對永續性重視的推動下，草銨膦的應用格局正在經歷一場變革。多個司法管轄區日益嚴格的環境和毒性評估流程迫使各公司重新評估其註冊策略，並加強投入以加強安全性和控制措施。同時，抗除草劑雜草數量的不斷增加凸顯了作用機制不同的替代除草劑的提案，使得草銨膦成為作物輪作計劃和綜合雜草管理通訊協定中的關鍵組成部分。

評估 2025 年關稅對供應鏈中斷的影響以及草銨膦採購、製造和打入市場策略的商業性成本。

2025年美國實施的關稅和貿易措施顯著改變了草銨膦價值鏈上相關企業的成本結構和採購決策。某些前驅物化學品和製劑原料關稅的提高增加了部分依賴進口的生產商的收貨成本，促使他們迅速重新評估供應商關係和物流模式。這項貿易政策的轉變凸顯了供應鏈透明度、多元化採購策略和本地生產方案對於維持獲利能力和供應連續性的重要性。

詳細的細分分析揭示了應用形式、作物配方和最終用途管道如何相互交織，從而塑造產品策略和商業化。

基於細分市場的洞察揭示了不同的需求促進因素和營運重點，這些因素會影響產品策略和市場策略。在考慮應用方式時，葉面噴布（分為播前和播後兩種情況）因其時間柔軟性且可在生長季期間進行干預，在田間決策中佔據主導地位。另一方面，種子處理和土壤施用則佔據著特定的應用領域，需要有針對性的殘留控制和幼苗保護。這些細微差別會影響配方選擇、噴灑設備規格以及面向諮詢管道的訊息。

對美洲、歐洲、中東和非洲以及亞太地區的需求促進因素、法規環境和供應鏈結構進行跨區域分析。

區域趨勢正在以截然不同的方式塑造美洲、歐洲、中東和非洲以及亞太地區的需求模式、監管風險和供應鏈結構。在美洲，多樣化的種植系統和大規模商業農業推動了對具有操作柔軟性的除草劑的強勁需求。同時，一些地區仍然保留著允許在嚴格控制下使用現有化學品的法規結構。南北之間的貿易流動和物流基礎設施也決定了配方創新到達生產商的速度，並影響活性成分的籌資策略。

競爭格局分析強調配方能力、監管彈性、生產規模和分銷能力作為核心差異化因素。

草銨膦價值鏈的競爭動態受多種因素影響，例如製劑技術、法規遵循、生產規模和銷售管道覆蓋範圍。擁有強大的研發能力和一體化生產能力的公司往往能夠保持價格柔軟性，並能更快地應對規格變更和需求激增。相反，依賴契約製造或供應鏈分散的公司更容易受到投入成本波動和貿易政策變化的影響，這可能導致利潤率下降和產品上市延遲。

為製造商、經銷商和顧問提供可操作的建議，以增強配方適應性、法規應對力、供應鏈敏捷性和全面商業策略。

產業領導企業可在草銨膦市場採取一系列措施，以保護利潤率、加速推廣應用並降低監管和供應鏈風險。優先考慮製劑多樣化，以滿足不同的施用時間和工人偏好，並投資開發符合當地設備標準和儲存條件的液體、乾粉和顆粒劑型。同時，擴大管理計畫和田間試驗項目，以驗證其在各種農業化學品條件下的功效，並支持在重點地區提交註冊申請。

採用透明、多方面的研究途徑，結合一手訪談、監管和供應鏈分析、專家檢驗和書面假設。

本執行摘要的研究結合了與行業相關人員的直接對話、對二手資料的嚴格檢驗以及反覆的專家評審，以確保提供平衡且切實可行的見解。主要資訊來源包括對農藝師、配方研發人員、供應鏈經理和監管專家的結構化訪談，從而直接了解田間層面的優先事項和商業限制因素。除這些訪談外，研究還涵蓋了分銷網路，以確定不同終端用戶管道和種植系統中產品推廣應用的促進因素。

策略結論強調了製劑創新、監管合作和供應鏈靈活性對於確保草銨膦長期重要性的重要性。

總而言之，草銨膦仍然是現代雜草管理的重要工具，但其未來的發展取決於相關人員能否有效應對監管壓力、供應鏈變化以及農民不斷變化的需求。關鍵挑戰包括投資配方創新、加強監管體係以及提高供應鏈柔軟性以抵禦關稅造成的成本波動。能夠積極調整產品開發以適應當地農業化學品需求和監管環境的公司，將更有利於維持市場准入和商業性競爭力。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：按作物分類的草銨膦市場

  • 玉米
  • 大豆
  • 小麥

第9章 按劑型分類的草銨膦市場

  • 乾液配方
  • 液體
  • 可濕性顆粒

第10章：草銨膦市場：依應用領域分類

  • 葉面噴布
    • 發芽後
    • 發芽前
  • 種子處理
  • 土壤

第11章 草銨膦市場：依最終用途分類

  • 商業農業
  • 工業的
  • 住宅

第12章 草銨膦市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章草銨膦市場：依組別

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 草銨膦市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國草銨膦市場

第16章：中國草銨膦市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • BASF SE
  • Best Agro Group
  • Cayman Chemical
  • Corteva Agriscience
  • Crystal Crop Protection Ltd.
  • Hebei Veyong Bio-Chemical Co., Ltd.
  • Icon Crop Science
  • Jiangsu Sevencontinent Green Chemical Co., Ltd.
  • Joshi Agrochem Pharma Pvt. Ltd.
  • King Quenson
  • Lier Chemical Co., Ltd.
  • National Analytical Corporation
  • Nufarm Ltd.
  • Peptech Biosciences Ltd.
  • SinoHarvest
  • Stephen Company
  • Super Ford Insecticides Ltd.
  • Syngenta AG
  • The Dow Chemical Company
  • UPL Ltd.
  • Veyong（Hebei Veyong Bio-Chemical Co. Ltd）
  • YongNong BioSciences Co., Ltd.
  • Zhengzhou Delong Chemical Co., Ltd.
Product Code: MRR-C002B1C994EB

The Glufosinate Market was valued at USD 2.17 billion in 2025 and is projected to grow to USD 2.39 billion in 2026, with a CAGR of 10.21%, reaching USD 4.29 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.17 billion
Estimated Year [2026] USD 2.39 billion
Forecast Year [2032] USD 4.29 billion
CAGR (%) 10.21%

Comprehensive introduction to the evolving glufosinate landscape outlining agronomic roles regulatory pressures supply chain dynamics and commercial relevance

Glufosinate occupies a distinct position within modern agronomy, serving as a non-glyphosate option in integrated weed control programs and as a complement to resistance management strategies. Its herbicidal mode of action, regulatory profile, and formulation flexibility have maintained relevance across diverse cropping systems, while shifting regulatory scrutiny and evolving grower preferences continually reshape how the product is deployed. Over recent seasons, stakeholders have balanced efficacy against environmental and regulatory considerations, prompting innovation in formulation, application timing, and stewardship practices.

Beyond agronomic performance, the product's commercial lifecycle is influenced by upstream raw material sourcing, formulant availability, and downstream regulatory approvals. As growers seek resilient weed control programs, demand patterns reflect both compliance drivers and practical field performance, with particular emphasis on crops where weed pressure and resistance risks are high. Consequently, manufacturers, formulators, and distributors are placing greater emphasis on integrated approaches that couple chemical tools with cultural and mechanical measures.

Looking ahead, the introduction outlines the cross-cutting forces shaping decisions across product development, market access, and on-farm adoption. By framing the landscape through regulatory dynamics, operational constraints, and end-user expectations, this section sets the context for deeper analysis of segmentation, regional dynamics, and strategic responses necessary for stakeholders to remain competitive and compliant.

Transformative regulatory agronomic technological and commercial forces reshaping glufosinate strategy innovation and supply chain positioning

The glufosinate landscape is undergoing transformative shifts driven by regulatory recalibration, resistance management needs, and a rising emphasis on sustainability. Stricter environmental and toxicological review processes across multiple jurisdictions have forced firms to reassess registration strategies and invest in enhanced safety and stewardship programs. Simultaneously, the proliferation of herbicide-resistant weed populations has elevated the value proposition of alternative modes of action, making glufosinate a strategic component of rotation programs and integrated weed management protocols.

Technological and commercial shifts are also apparent. Formulation science is advancing to improve rainfastness, crop selectivity, and tank-mix compatibility, thereby expanding operational windows for applicators. Digital agronomy tools are enabling precision application that reduces active ingredient use while maximizing efficacy, and analytics-driven decision support is helping advisors prescribe combinations that delay resistance onset. On the supply side, consolidation among formulators and distributors continues to reshape access and pricing dynamics, with partnerships and contract manufacturing playing an increasingly important role.

Moreover, sustainability commitments from major buyers and retailers are pressuring supply chains to demonstrate lower environmental footprints and robust stewardship. This confluence of regulatory oversight, agronomic necessity, and commercial sustainability requirements is driving portfolio rationalization and innovation, creating both challenges and opportunities for incumbents and new entrants alike.

Assessment of the 2025 tariff-driven supply chain disruptions and commercial cost implications for glufosinate sourcing manufacturing and market access strategies

The imposition of tariffs and trade measures in the United States in 2025 has materially altered cost structures and sourcing decisions for players within the glufosinate value chain. Increased duties on certain precursor chemicals and formulation inputs have elevated landed costs for some import-dependent manufacturers, prompting rapid reassessment of supplier relationships and logistics models. These trade policy shifts have emphasized the importance of supply-chain visibility, multi-sourcing strategies, and localized manufacturing options to preserve margin and maintain supply continuity.

As a consequence, manufacturers and formulators have had to weigh the trade-offs between passing higher costs to downstream customers and absorbing margin compressions. In many cases, commercial teams implemented targeted price adjustments alongside enhanced value messaging to justify changes, while procurement functions accelerated qualification of alternative suppliers from lower-tariff jurisdictions. The tariff environment also strengthened incentives for forward contracting and inventory hedging, with companies balancing working capital impacts against the need to avoid program disruptions during peak application seasons.

Importantly, the tariff landscape created a differential impact across segments and regions, benefiting firms with integrated domestic production or those with secure access to tariff-exempt supply chains. It also stimulated conversations about nearshoring and co-locating formulation capacity closer to key demand centers. Collectively, these developments have underscored the necessity of proactive trade-policy monitoring and agile commercial responses to preserve competitiveness in a recalibrated cost environment.

Nuanced segmentation analysis revealing how application modes crops formulations and end-use channels intersect to shape product strategy and commercialization

Segmentation-driven insights reveal differentiated demand drivers and operational priorities that influence product strategy and go-to-market approaches. When examined by application, foliar use-divided into post-emergence and pre-emergence scenarios-dominates field-level decision-making due to flexibility in timing and compatibility with in-season interventions, while seed treatment and soil applications serve niche roles where targeted residual control or seedling protection is required. These subtleties impact formulation choices, application equipment specifications, and stewardship messaging for advisory channels.

Crop-based segmentation shows that crops such as corn, soybean, and wheat present distinct use-case patterns rooted in cropping cycles, weed spectra, and tolerance profiles. Corn programs frequently emphasize knockdown and in-season rolling programs that integrate glufosinate with other herbicides to manage diverse weed mixes, whereas soybean programs may prioritize pre-harvest or targeted post-emergence interventions that align with herbicide-tolerance traits. Wheat systems often require attention to pre-emergence residual control and selective tank mixes to protect yield potential during early growth stages.

Formulation preferences-spanning dry flowable, liquid, and water dispersible granules-reflect trade-offs between handling convenience, solubility, spray stability, and on-farm equipment compatibility. Dry flowables can reduce shipping weight and risk, liquids offer ease of mixing and rapid uptake, and water dispersible granules provide precise dosing and improved storage stability for certain channels. End-use segmentation into commercial agriculture, industrial, and residential applications further modulates product characteristics and regulatory demands, with commercial agriculture driving scale and cost-efficiency, industrial uses requiring tailored labeling and safety controls, and residential applications focusing on low-dose, user-friendly formats.

Together, these segmentation layers intersect to define customer value propositions, distribution strategies, and R&D priorities. Understanding how application mode, crop type, formulation choice, and end-use context interact is essential for designing products and commercial approaches that meet field-level expectations while satisfying regulatory and channel constraints.

Cross-regional analysis of demand drivers regulatory environments and supply chain structures across the Americas Europe Middle East & Africa and Asia-Pacific

Regional dynamics shape demand patterns, regulatory exposure, and supply chain architectures in materially different ways across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, diverse cropping systems and large-scale commercial agriculture create robust demand for operationally flexible herbicides, while regulatory frameworks in some jurisdictions remain conducive to the use of established chemistries under strict stewardship. North-South trade flows and logistical infrastructure also determine how quickly formulation innovations reach growers and influence procurement strategies for active ingredients.

Within Europe, Middle East & Africa, regulatory scrutiny is often intense and variable by sub-region, with some markets enforcing stringent environmental assessments and others prioritizing access for essential agricultural inputs. This uneven regulatory landscape compels firms to pursue targeted registrations and localized safety data packages, and it elevates the importance of demonstrating compliance with regional sustainability expectations. Market access in these geographies frequently hinges on robust data packages and demonstrated stewardship programs.

In the Asia-Pacific region, high-intensity cropping systems and fast-adopting grower communities create demand for both high-efficacy solutions and specialized formulations that accommodate local practices. Regional manufacturing hubs and proximate raw material suppliers can offer cost advantages, but regulatory variability and complex import regimes require careful navigation. Across all regions, local distribution networks, extension services, and channel partners significantly influence adoption velocity, making regionally tailored commercialization strategies essential for success.

Competitive landscape analysis emphasizing formulation capability regulatory agility manufacturing scale and distribution strength as core differentiators

Competitive dynamics in the glufosinate value chain are shaped by capabilities in formulation, regulatory affairs, production scale, and channel reach. Firms that combine robust R&D with integrated manufacturing capacity tend to retain pricing flexibility and can respond more rapidly to specification changes or sudden demand spikes. Conversely, companies that rely on contract manufacturing or fragmented supply chains are more exposed to input cost volatility and trade-policy shifts, which can compress margins or delay product launches.

Strategic behaviors observed in the sector include portfolio rationalization to focus on high-performing formulations, targeted acquisitions to acquire formulation technology or regional registrations, and co-development agreements that accelerate market entry while sharing regulatory risk. Investment in application technology and stewardship programs also differentiates leading companies, as buyers increasingly demand verifiable safety and efficacy data. Distribution strength remains a critical competitive advantage, with networks that combine agronomic advisory services and after-sales support proving particularly effective at driving adoption among commercial growers.

Additionally, companies investing in digital agronomy and decision-support tools are creating stickier customer relationships by embedding product recommendations within broader crop management platforms. Those that couple product performance with demonstrable environmental and occupational safety measures are better positioned to meet the convergence of regulatory and buyer-driven sustainability requirements, thereby protecting market access and premium positioning.

Actionable recommendations for manufacturers distributors and advisors to enhance formulation resilience regulatory readiness supply-chain agility and integrated commercial strategies

Industry leaders can adopt a series of practical measures to protect margins, accelerate adoption, and reduce regulatory and supply-chain risk in the glufosinate market. Prioritize formulation diversification to address varied application windows and handler preferences, investing in liquid, dry flowable, and granule formats that align with local equipment norms and storage realities. At the same time, expand stewardship and field-trial programs that document efficacy under diverse agronomic conditions and support registration dossiers across priority jurisdictions.

Strengthen supply-chain resilience by qualifying multiple suppliers for critical inputs, negotiating flexible sourcing agreements, and considering localized blending or co-packing to mitigate tariff exposure. Use predictive procurement and inventory management to balance cost against the operational risk of stockouts during peak seasons. Enhance regulatory engagement by proactively investing in safety and environmental datasets, participating in industry working groups to influence policy timelines, and maintaining transparent communication with regulators to expedite approvals when possible.

Finally, embed product offerings within broader crop management solutions by partnering with digital agronomy providers, offering decision-support tools, and training advisory channels on integrated weed management. These integrated approaches increase product relevance, reduce reliance on single-technology solutions, and enable commercial teams to articulate a compelling value proposition that justifies premium positioning while promoting long-term stewardship.

Transparent multi-method research approach integrating primary interviews regulatory and supply-chain analysis with expert validation and documented assumptions

The research underpinning this executive summary combined primary engagement with industry stakeholders, rigorous secondary-source validation, and iterative expert review to ensure balanced and actionable findings. Primary inputs included structured interviews with agronomists, formulators, supply-chain managers, and regulatory specialists, enabling direct observation of field-level priorities and commercial constraints. These interviews were complemented by targeted surveys of distribution networks to capture adoption drivers across different end-use channels and cropping systems.

Secondary research encompassed regulatory filings, peer-reviewed agronomic studies, formulation patents, and trade policy publications to contextualize primary observations and identify cross-jurisdictional patterns. Supply-chain mapping exercises traced key material flows, identified concentration risks in precursor supply, and evaluated potential impacts from tariff scenarios. All data points were cross-checked against multiple sources and reviewed by an expert panel to reconcile divergent perspectives and ensure analytic rigor.

To enhance reproducibility and transparency, methodologies for segmentation, regional analysis, and impact assessment were documented with decision rules, inclusion criteria, and assumptions. Sensitivity analyses were performed to understand how variations in regulatory timelines, tariff levels, and weed-resistance prevalence could influence strategic priorities, thereby providing stakeholders with a framework to adapt recommendations to their specific risk tolerance and operational constraints.

Strategic conclusion emphasizing the importance of formulation innovation regulatory engagement and supply-chain agility to secure long-term glufosinate relevance

In conclusion, glufosinate remains an important tool within modern weed management arsenals, but its future trajectory is contingent on how well stakeholders navigate regulatory pressures, supply-chain shifts, and evolving grower expectations. Key imperatives include investing in formulation innovation, strengthening stewardship frameworks, and enhancing supply-chain flexibility to withstand tariff-driven cost volatility. Firms that proactively align product development with region-specific agronomic needs and regulatory realities will be better positioned to sustain market access and commercial relevance.

The road ahead favors those who can couple technical excellence with operational agility and clear value communication to customers. By integrating glufosinate offerings into broader crop management solutions and by demonstrating measurable safety and environmental performance, companies can preserve margins and unlock growth opportunities even as the market environment becomes more complex. Ultimately, strategic focus, evidence-based regulatory engagement, and disciplined execution will determine which organizations successfully convert current challenges into long-term advantage.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Glufosinate Market, by Crop

  • 8.1. Corn
  • 8.2. Soybean
  • 8.3. Wheat

9. Glufosinate Market, by Formulation

  • 9.1. Dry Flowable
  • 9.2. Liquid
  • 9.3. Water Dispersible Granules

10. Glufosinate Market, by Application

  • 10.1. Foliar
    • 10.1.1. Post Emergence
    • 10.1.2. Pre Emergence
  • 10.2. Seed Treatment
  • 10.3. Soil

11. Glufosinate Market, by End Use

  • 11.1. Commercial Agriculture
  • 11.2. Industrial
  • 11.3. Residential

12. Glufosinate Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Glufosinate Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Glufosinate Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Glufosinate Market

16. China Glufosinate Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. BASF SE
  • 17.6. Best Agro Group
  • 17.7. Cayman Chemical
  • 17.8. Corteva Agriscience
  • 17.9. Crystal Crop Protection Ltd.
  • 17.10. Hebei Veyong Bio-Chemical Co., Ltd.
  • 17.11. Icon Crop Science
  • 17.12. Jiangsu Sevencontinent Green Chemical Co., Ltd.
  • 17.13. Joshi Agrochem Pharma Pvt. Ltd.
  • 17.14. King Quenson
  • 17.15. Lier Chemical Co., Ltd.
  • 17.16. National Analytical Corporation
  • 17.17. Nufarm Ltd.
  • 17.18. Peptech Biosciences Ltd.
  • 17.19. SinoHarvest
  • 17.20. Stephen Company
  • 17.21. Super Ford Insecticides Ltd.
  • 17.22. Syngenta AG
  • 17.23. The Dow Chemical Company
  • 17.24. UPL Ltd.
  • 17.25. Veyong (Hebei Veyong Bio-Chemical Co. Ltd)
  • 17.26. YongNong BioSciences Co., Ltd.
  • 17.27. Zhengzhou Delong Chemical Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL GLUFOSINATE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GLUFOSINATE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL GLUFOSINATE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL GLUFOSINATE MARKET SIZE, BY CROP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL GLUFOSINATE MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GLUFOSINATE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL GLUFOSINATE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GLUFOSINATE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES GLUFOSINATE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA GLUFOSINATE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL GLUFOSINATE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL GLUFOSINATE MARKET SIZE, BY CROP, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL GLUFOSINATE MARKET SIZE, BY CORN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL GLUFOSINATE MARKET SIZE, BY CORN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL GLUFOSINATE MARKET SIZE, BY CORN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL GLUFOSINATE MARKET SIZE, BY SOYBEAN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL GLUFOSINATE MARKET SIZE, BY SOYBEAN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL GLUFOSINATE MARKET SIZE, BY SOYBEAN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL GLUFOSINATE MARKET SIZE, BY WHEAT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL GLUFOSINATE MARKET SIZE, BY WHEAT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL GLUFOSINATE MARKET SIZE, BY WHEAT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL GLUFOSINATE MARKET SIZE, BY DRY FLOWABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL GLUFOSINATE MARKET SIZE, BY DRY FLOWABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL GLUFOSINATE MARKET SIZE, BY DRY FLOWABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL GLUFOSINATE MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL GLUFOSINATE MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL GLUFOSINATE MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL GLUFOSINATE MARKET SIZE, BY WATER DISPERSIBLE GRANULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL GLUFOSINATE MARKET SIZE, BY WATER DISPERSIBLE GRANULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL GLUFOSINATE MARKET SIZE, BY WATER DISPERSIBLE GRANULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL GLUFOSINATE MARKET SIZE, BY FOLIAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL GLUFOSINATE MARKET SIZE, BY FOLIAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL GLUFOSINATE MARKET SIZE, BY FOLIAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL GLUFOSINATE MARKET SIZE, BY POST EMERGENCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL GLUFOSINATE MARKET SIZE, BY POST EMERGENCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL GLUFOSINATE MARKET SIZE, BY POST EMERGENCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL GLUFOSINATE MARKET SIZE, BY PRE EMERGENCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL GLUFOSINATE MARKET SIZE, BY PRE EMERGENCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL GLUFOSINATE MARKET SIZE, BY PRE EMERGENCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL GLUFOSINATE MARKET SIZE, BY SEED TREATMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL GLUFOSINATE MARKET SIZE, BY SEED TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL GLUFOSINATE MARKET SIZE, BY SEED TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL GLUFOSINATE MARKET SIZE, BY SOIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL GLUFOSINATE MARKET SIZE, BY SOIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL GLUFOSINATE MARKET SIZE, BY SOIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL GLUFOSINATE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL GLUFOSINATE MARKET SIZE, BY COMMERCIAL AGRICULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GLUFOSINATE MARKET SIZE, BY COMMERCIAL AGRICULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL GLUFOSINATE MARKET SIZE, BY COMMERCIAL AGRICULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL GLUFOSINATE MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL GLUFOSINATE MARKET SIZE, BY INDUSTRIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL GLUFOSINATE MARKET SIZE, BY INDUSTRIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL GLUFOSINATE MARKET SIZE, BY RESIDENTIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL GLUFOSINATE MARKET SIZE, BY RESIDENTIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL GLUFOSINATE MARKET SIZE, BY RESIDENTIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL GLUFOSINATE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS GLUFOSINATE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS GLUFOSINATE MARKET SIZE, BY CROP, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS GLUFOSINATE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 56. NORTH AMERICA GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA GLUFOSINATE MARKET SIZE, BY CROP, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA GLUFOSINATE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA GLUFOSINATE MARKET SIZE, BY CROP, 2018-2032 (USD MILLION)
  • TABLE 64. LATIN AMERICA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA GLUFOSINATE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE, MIDDLE EAST & AFRICA GLUFOSINATE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA GLUFOSINATE MARKET SIZE, BY CROP, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA GLUFOSINATE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE GLUFOSINATE MARKET SIZE, BY CROP, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE GLUFOSINATE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 80. MIDDLE EAST GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. MIDDLE EAST GLUFOSINATE MARKET SIZE, BY CROP, 2018-2032 (USD MILLION)
  • TABLE 82. MIDDLE EAST GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 83. MIDDLE EAST GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. MIDDLE EAST GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2032 (USD MILLION)
  • TABLE 85. MIDDLE EAST GLUFOSINATE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 86. AFRICA GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. AFRICA GLUFOSINATE MARKET SIZE, BY CROP, 2018-2032 (USD MILLION)
  • TABLE 88. AFRICA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 89. AFRICA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. AFRICA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2032 (USD MILLION)
  • TABLE 91. AFRICA GLUFOSINATE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC GLUFOSINATE MARKET SIZE, BY CROP, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC GLUFOSINATE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL GLUFOSINATE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. ASEAN GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. ASEAN GLUFOSINATE MARKET SIZE, BY CROP, 2018-2032 (USD MILLION)
  • TABLE 101. ASEAN GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 102. ASEAN GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. ASEAN GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2032 (USD MILLION)
  • TABLE 104. ASEAN GLUFOSINATE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 105. GCC GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GCC GLUFOSINATE MARKET SIZE, BY CROP, 2018-2032 (USD MILLION)
  • TABLE 107. GCC GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 108. GCC GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. GCC GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2032 (USD MILLION)
  • TABLE 110. GCC GLUFOSINATE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPEAN UNION GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPEAN UNION GLUFOSINATE MARKET SIZE, BY CROP, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPEAN UNION GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPEAN UNION GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPEAN UNION GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPEAN UNION GLUFOSINATE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 117. BRICS GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. BRICS GLUFOSINATE MARKET SIZE, BY CROP, 2018-2032 (USD MILLION)
  • TABLE 119. BRICS GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 120. BRICS GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. BRICS GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2032 (USD MILLION)
  • TABLE 122. BRICS GLUFOSINATE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 123. G7 GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. G7 GLUFOSINATE MARKET SIZE, BY CROP, 2018-2032 (USD MILLION)
  • TABLE 125. G7 GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 126. G7 GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. G7 GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2032 (USD MILLION)
  • TABLE 128. G7 GLUFOSINATE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 129. NATO GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. NATO GLUFOSINATE MARKET SIZE, BY CROP, 2018-2032 (USD MILLION)
  • TABLE 131. NATO GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 132. NATO GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. NATO GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2032 (USD MILLION)
  • TABLE 134. NATO GLUFOSINATE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. UNITED STATES GLUFOSINATE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 137. UNITED STATES GLUFOSINATE MARKET SIZE, BY CROP, 2018-2032 (USD MILLION)
  • TABLE 138. UNITED STATES GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 139. UNITED STATES GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. UNITED STATES GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2032 (USD MILLION)
  • TABLE 141. UNITED STATES GLUFOSINATE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 142. CHINA GLUFOSINATE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 143. CHINA GLUFOSINATE MARKET SIZE, BY CROP, 2018-2032 (USD MILLION)
  • TABLE 144. CHINA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 145. CHINA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. CHINA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2032 (USD MILLION)
  • TABLE 147. CHINA GLUFOSINATE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)